...
【24h】

Survival Outcomes in Surgical Treatment of 72 Cases of Squamous Cell Carcinoma of the Temporal Bone

机译:72例颞骨鳞状细胞癌的手术治疗中的生存结果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: To evaluate surgical outcomes for squamous cell carcinoma of the temporal bone. Study Design: Retrospective study. Setting: Eye and ENT Hospital.Methods: Seventy-two patients with squamous cell carcinoma of the temporal bone were analyzed for survival. The patients were staged according to the modified Pittsburgh staging system. Five patients with Tl cancers underwent local resection (LR), and 10 patients with Tl cancers underwent lateral temporal bone resection (LTBR). Two patients with T2 cancers underwent LR, and 1 patient with T2 cancer underwent LTBR. One patient with T3 cancer underwent LR, 8 patients with T3 cancers underwent LTBR, and 10 patients with T3 cancers underwent subtotal temporal bone resection (STBR). Ten patients with T4 cancers underwent LTBR, and 25 patients with T4 cancers underwent STBR.Results: Of all patients that underwent surgery, 18 died of their disease during the follow-up time. The 5-year survival rates of patients with T stages 1 through 4 were 100%, 67%, 21%, and 14%, respectively. There was no statistically significant difference in 5-year survival rate between T3 and T4 using the log-rank test O > 0.05). The 5-year survival rates after LTBR and STBR for T3 were 26% and 16% (p > 0.05), respectively, and those for T4 were 17% and 11% (p > 0.05), respectively. Conclusion: An eh bloc resection is favored in an effort to produce negative surgical margins for squamous cell carcinoma of the.temporal bone. Adjunctive radiotherapy is used for advanced lesions.
机译:目的:评估颞骨鳞状细胞癌的手术结局。研究设计:回顾性研究。环境:ENT医院。方法:分析了颞骨鳞状细胞癌的72例生存。根据修改后的匹兹堡分期系统,将患者分期。 5例TL癌症患者接受了局部切除(LR),10例TL癌症患者接受了侧骨切除术(LTBR)。两名T2癌症患者接受了LR,1例T2癌患者接受了LTBR。一名T3癌症患者接受了LR,8例T3癌症患者接受了LTBR,10例T3癌症患者接受了颞骨切除次数(STBR)。十名T4癌症患者接受了LTBR,25例T4癌症患者接受了STBR。分析:在所有接受手术的患者中,有18例在随访期间死于其疾病。 T阶段1至4的患者的5年生存率分别为100%,67%,21%和14%。使用对数秩检验O> 0.05,T3和T4之间的5年生存率在5年生存率上没有统计学上的显着差异。 T3的LTBR和STBR后的5年生存率分别为26%和16%(P> 0.05),T4的生存率分别为17%和11%(P> 0.05)。结论:EH集团切除术是为了产生颞骨鳞状细胞癌的阴性手术缘。辅助放疗用于晚期病变。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号